Hematogones in patients with acute myeloid leukaemia: Prognostic value and correlation with minimal residual disease

Hematogones in patients with acute myeloid leukaemia: Prognostic value and correlation with minimal residual disease

Bibliographic Details
Main Authors:	Rita Tavarozzi, Enrica Manzato, Riccardo Morganti, Paola Sammuri, Giulia Tarrini, Federica Ricci, Giordana Mattana, Sara Galimberti, Mario Petrini, Giovanni Carulli
Format:	Article
Language:	English
Published:	Elsevier 2021-01-01
Series:	Leukemia Research Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213048921000017

Similar Items

Multiparameter flow cytometry to detect hematogones and to assess B-lymphocyte clonality in bone marrow samples from patients with non-Hodgkin lymphomas
by: Giovanni Carulli, et al.
Published: (2014-06-01)

The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients
by: Serena Salehzadeh, et al.
Published: (2019-04-01)

The Role of Bispecific Antibodies in Non-Hodgkin’s Lymphoma: From Structure to Prospective Clinical Use
by: Rita Tavarozzi, et al.
Published: (2022-02-01)

Observations on hematogones with light chain restriction.
by: Angela D'Ardia, et al.
Published: (2022-01-01)

Hematogones: The Supreme Mimicker and a Cytomorphological Confounder in Acute Lymphoblastic Leukemia
by: Kanwaljeet Singh, et al.
Published: (2023-06-01)

Pseudo-Kappa Light Chain Restricted Hematogones in Patients Receiving Daratumumab
by: Hamza Tariq, et al.
Published: (2022-02-01)

The importance of immunophenotyping by flow cytometry in distinction between hematogones and B lymphoblasts
by: Aline B. Wohlfahrt, et al.
Published: (2015-02-01)

PB1753: EVALUATION OF IMMUNOPHENOTYPIC CHARACTERISTICS OF RESIDUAL CELLS IN COMPARISON WITH NORMAL HEMATOGONES AND MATURE CELLS IN CHILDREN WITH B-CELL LYMPHOBLASTIC LEUKEMIA
by: Oksana Karnabeda, et al.
Published: (2023-08-01)

Acute Myeloid Leukaemia with Plasmacytosis
by: Yasmin Akhtar, Saqib Qayyum Ahmad, Shahid Jamal
Published: (2016-12-01)

Exploring the acute myeloid leukaemias
by: TB Thapa
Published: (2013-10-01)

Clonal structures of leukaemia stem cell populations in myeloid blast phase chronic myeloid leukaemia
by: Karamitros, D, et al.
Published: (2016)

Harnessing the graft-versus-leukaemia effect in acute myeloid leukaemia
by: Sweeney, C
Published: (2021)

Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia
by: Lutz, C, et al.
Published: (2013)

Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia.
by: Lutz, C, et al.
Published: (2013)

Secondary acute myeloid leukaemia in children treated for acute lymphoblastic leukaemia.
by: Eden, O, et al.
Published: (1998)

Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia.
by: Guinn, B, et al.
Published: (2005)

Molecular Mechanisms and Therapies of Myeloid Leukaemia
by: Elliott Brown, et al.
Published: (2022-06-01)

Chronic myeloid leukaemia with marked thrombocytosis
by: Jun Ooi, et al.
Published: (2021-02-01)

Mortality in paediatric acute myeloid leukaemia
Published: (2020-10-01)

Adhesion Deregulation in Acute Myeloid Leukaemia
by: Alicja M. Gruszka, et al.
Published: (2019-01-01)

Wnt Signalling in Acute Myeloid Leukaemia
by: Alicja M. Gruszka, et al.
Published: (2019-11-01)

Orbital deposit in acute myeloid leukaemia
by: Seal G, et al.
Published: (1973-01-01)

Unprecedented behaviour of chronic myeloid leukaemia
by: Balambika RG, et al.
Published: (2016-07-01)

Bilateral proptosis with acute myeloid leukaemia
by: Hafeez Ahmad S, et al.
Published: (1971-01-01)

THE SIGNIFICANCE OF MINIMAL RESIDUAL DISEASE IN ACUTE LYMPHOBLASTIC LEUKAEMIA: A SINGLE CENTRE STUDY
by: Abdulrahman A. Muhsin, et al.
Published: (2024-04-01)

Assessment of minimal residual disease in acute myeloid leukemia.
by: Grimwade, D, et al.
Published: (2010)

Liquid biopsies and minimal residual disease in myeloid malignancies
by: Sabine Allam, et al.
Published: (2023-05-01)

Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results
by: Rita Fazzi, et al.
Published: (2021-02-01)

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
by: R Edlin, et al.
Published: (2010-05-01)

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
by: R Edlin, et al.
Published: (2010-05-01)

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
by: Boultwood, J, et al.
Published: (2004)

B-cell precursors (hematogones) in CD34+ hematopoietic stem cell collections: a single-center experience
by: Daniel Mazza Matos
Published: (2022-09-01)

The Presence of Precursors of Benign Pre-B Lymphoblasts (Hematogones) in the Bone Marrow of a Paediatric Patient with Cytomegalovirus Infection
by: F Moreno-Madrid, et al.
Published: (2008-01-01)

Metabolomic profiling identifies pathways associated with minimal residual disease in childhood acute lymphoblastic leukaemia
by: Jeremy M. Schraw, et al.
Published: (2019-10-01)

EVI1 expression in acute myeloid leukaemia.
by: Langabeer, SE, et al.
Published: (2001)

C/EBPalpha mutations in acute myeloid leukaemias.
by: Nerlov, C
Published: (2004)

Immunological weapons against acute myeloid leukaemia.
by: Galea-Lauri, J
Published: (2002)

Amplification of mitochondrial DNA in acute myeloid leukaemia.
by: Boultwood, J, et al.
Published: (1996)

New Therapeutic Approaches for Acute Myeloid Leukaemia
by: Ruth M Risueno, et al.
Published: (2021-06-01)

The Mutational Landscape of Myeloid Leukaemia in Down Syndrome
by: Carini Picardi Morais de Castro, et al.
Published: (2021-08-01)